Latest | Summary of medical device data from various provinces and cities

01
General Overview

According to the statistics of the Data Center of the High – end Medical Device Institute, as of June 30, 2025, there were 35,359 medical device manufacturing enterprises within the territory of China, an increase of 5.86% compared with the end of 2024 (35,153 enterprises). Looking at the overall trend of the number of medical device manufacturing enterprises in China from 2021 to 2025, the industry scale has shown a continuous expansion trend. In 2021, the number of medical device manufacturing enterprises in China was 28,776, and by 2025, it had increased to 35,359. Although the growth has slowed down in the past four years and entered a short – term adjustment period, the overall upward trend is clear.

Among them, there are 23,499 enterprises that can produce Type I products, an increase of 3.20% compared with the end of 2024. There are 18,264 enterprises that can produce Type II products and 3,189 enterprises that can produce Type III products, with growth rates of 1.56% and 2.38% respectively.

02
The number of manufacturing enterprises in each province and city

From the perspective of provincial distribution, as of June 2025, Guangdong Province still ranks first in the number of medical device manufacturers in China, with a total of 5,402 companies, accounting for 15.79% of the national total. Followed by Jiangsu Province and Shandong Province, with 51,345 and 4,463 companies respectively. Among them, the competition between Jiangsu and Guangdong in the battle for the first place is particularly intense, with a proportion gap of less than 0.8%.
Compared with the same period in 2024, the three provinces with the most significant growth rates are Guizhou Province (21.43%), Guangxi Zhuang Autonomous Region (16.48%), and Henan Province (9.11%). The province with the most significant increase in quantity is Jiangsu Province, with 384 more enterprises compared with the same period in 2024. There is also a decrease in the number of enterprises in a small number of provinces, specifically Gansu Province (-5.00%), Jilin Province (4.38%), Jiangxi Province (-1.98%), and Shaanxi Province (-1.01%).
From the perspective of urban distribution, as of June 30, 2025, the city with the largest number of medical device manufacturers in China is Shenzhen, with 1,660 manufacturers. Suzhou ranks second with 1,401 manufacturers, and Shanghai ranks third with 1,270 manufacturers.
By comparing the TOP 50 city rankings for the whole year of 2024 and the first half of 2025, it can be found that compared with the TOP 50 cities in 2024, Xiantao City and Nanning City are newly listed in the rankings in the first half of 2025, while Huizhou City and Yancheng City unfortunately dropped out. Moreover, Xiantao City has leaped to the 35th place in the ranking, from which it can be inferred from the data that there has been a certain breakthrough in the local medical device industry in the past year.
Instructions: The data statistics period for 2024 ends on December 25, 2024.
By comparing the growth and decline rates of the number of enterprises in the TOP 50 cities in the first half of 2025 with those in the corresponding cities in 2024, it can be found that except for Xiantao City, the city with the fastest growth rate is Xiamen (5.33%), while the cities with the largest decline are Shenyang (-2.87%) and Changchun (-2.44%). The leading cities “show a steady increase”. Shenzhen, Suzhou, Shanghai, Beijing, and Guangzhou rank among the top five, with growth rates ranging from 0.25% to 4.17%.
The industrial cluster effect is significant (such as Shenzhen’s electronic information and Suzhou’s high – end manufacturing), continuously attracting enterprises to settle in. “Zero – growth” special case: Nanchang, with the number of enterprises both in the first half of 2024 and 2025 being 357, and the growth rate being 0%. The industrial structure is stable (such as a high proportion of traditional manufacturing), with no obvious expansion or contraction. • Medium – sized cities show obvious differentiation. High – growth representatives (Yangzhou, Nanjing, Xiamen): The growth rate is 4.21% – 5.33%. Benefiting from the policy dividends of the Yangtze River Delta integration, emerging industries (such as Yangzhou’s new energy and Nanjing’s software) are developing rapidly. High – deceleration representatives (Shenyang, Changchun, Zhuhai): The deceleration is 1.53% – 2.87%, exposing the transformation pressure of traditional industries (such as Zhuhai’s electronic OEM and the heavy industry in Northeast China).

03
The production situations of Class II and Class III enterprises in each province (autonomous region, municipality directly under the Central Government)

By ranking the number of enterprises in each province that can produce Class III medical devices in the first half of 2024 and 2025, it can be found that the rankings of Anhui Province, Yunnan Province, and Inner Mongolia Autonomous Region have declined. In terms of the number of enterprises that can produce Class III medical devices, Jiangsu currently ranks first with 731 enterprises, while Guangdong Province and Beijing rank second and third with 463 and 346 enterprises respectively. In terms of the increase and decrease trend, the province with the largest increase in the number of enterprises that can produce Class III medical devices in the first half of 2025 is Jiangsu Province, with an increase of 20 enterprises. Besides the increase in the number of enterprises in Jiangsu, the number of enterprises in the rest of the provinces has either decreased or remained unchanged. Among them, the province with the largest decrease is Shanghai, with a decrease of 25 enterprises.
From the ranking of the number of enterprises in each province that can produce Class II medical devices in the first half of 2025: Shanghai, Hebei Province, Jiangxi Province, Liaoning Province, and Jilin Province have experienced a decline in the provincial ranking. In terms of the number of enterprises that can produce Class II medical devices, Guangdong ranks first with 3,165 enterprises, while Jiangsu Province and Zhejiang Province rank second and third with 2,471 and 1,411 enterprises respectively. In terms of the increase and decrease trend, the province with the largest increase in the number of enterprises that can produce Class II medical devices in the first half of 2025 is Jiangsu Province, with an increase of 33 enterprises. Next are Guangxi Province and Guizhou Province, with an increase of 14 and 9 enterprises respectively. The number of enterprises in most provinces is either decreasing or remaining unchanged. Among them, the provinces with the largest decrease are Guangdong Province, Hunan Province, and Liaoning Province, with a decrease of 135, 108, and 74 enterprises respectively.

04
Production situation of Class II and Class III enterprises in key cities

In the first half of 2025, the top three cities in terms of the stock of enterprises capable of producing Class III products were Beijing (346 enterprises), Shanghai (302 enterprises), and Suzhou (257 enterprises). In the ranking of the number of producible enterprises, compared with 2024, the overall ranking order of the top 10 cities in the first half of 2025 did not change significantly. Only Wuhan dropped out of the top rankings, and Wuxi successfully filled the position. During this half – year period, among the top 10 cities in terms of the number of enterprises capable of producing Class III products, Suzhou had the largest growth rate compared with the end of 2024 (7.98%), and Suzhou also had the largest increase in the number of enterprises, with an increase of 19. The most significant decline in proportion was in Shanghai (-3.21%), and it was also the only city among the top 10 that experienced a decrease. The number of enterprises in Shanghai decreased by 10 during the half – year period.
According to the latest TOP10 of enterprises that can produce Class II products in the first half of 2025, compared with 2024, the rankings of Beijing and Suzhou have both increased within half a year. Suzhou has even advanced three places at one go and come to the fourth place. In terms of the increase and decrease of enterprises, 150 enterprises have been added, with a growth rate of 27.73%. Secondly, the increase in Tianjin has reached 29 enterprises, with a growth rate of 11.95%. In half a year, Shanghai has the largest number of enterprises decreased, with 24 enterprises decreased, a decrease of 3.31%. Secondly, Changsha has 20 enterprises decreased, a decrease of 3.02%.
Overall, in the first half of 2025, the development of national medical device manufacturers in China showed the characteristics of scale growth and regional differentiation. From the perspective of enterprise types, the number of manufacturers of Class II and Class III products is still increasing, reflecting that innovative products with higher technological content play a more important role in the industry. From the perspective of regional distribution, economically developed provinces such as Guangdong, Jiangsu, and Shandong are still the core regions of medical device production, while some central and western regions are growing rapidly, showing a trend of regional gradient expansion of the industry. Key cities such as Shenzhen, Beijing, Shanghai, and Suzhou not only lead far in the number of enterprises but also stand out in the production capacity of high – end products. In particular, Suzhou is far ahead in the increase of manufacturers of Class II and Class III products. Looking to the future, the medical device industry faces both broad development opportunities and many challenges. With the continuous progress of science and technology, emerging technologies such as artificial intelligence, big data, and the Internet of Things will be further integrated into the medical device field, promoting the development of products towards intelligence and personalization. At the same time, the intensification of population aging and the improvement of residents’ health awareness will continuously expand the demand for the medical device market. However, the industry competition will become increasingly fierce. On the one hand, competition among domestic enterprises will continue to intensify. Leading enterprises will further consolidate their advantages, and enterprises in mid – tier and lower – tier cities need to compete for market share through innovation and differentiated competition. On the other hand, with the development of global economic integration, foreign medical device giants will also increase their layout in the Chinese market, and domestic enterprises will face competitive pressure from the international market.

China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com

Source | Medical Device Innovation Network, High – end Medical Device Institute